+499.5%
MRNA vs ARMK
+47.4%
+452.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ARMK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.4% | -2.2% |
| 7D | +5.5% | -2.4% | +7.9% | +5.7% |
| 30D | +158.7% | 0.0% | +158.7% | +153.9% |
| 3M | +182.1% | +6.7% | +175.5% | +170.1% |
| 6M | +151.8% | +38.8% | +113.0% | +111.4% |
| YTD | +393.6% | +55.2% | +338.4% | +282.1% |
| 1Y | +499.5% | +46.6% | +452.9% | +382.6% |
| All | +499.5% | +47.4% | +452.1% | +382.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ARMK.
Daily Out/Under-Performance
Portfolio return minus ARMK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARMK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ARMK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling